Organon projects over $1B in Nexplanon revenue for 2025 amid continued expansion

May 01, 2025 11:33 AM ETOrganon & Co. (OGN) StockAI-Generated Earnings Calls Insights
(5min)

Earnings Call Insights: Organon & Co. (OGN) Q1 2025

Management View

  • CEO Kevin Ali stated that Q1 2025 results met expectations, with Nexplanon achieving double-digit growth and projected to exceed $1 billion in revenue for the year. He highlighted the success of the
Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking Alpha website. The insights are generated by an AI tool and have not been curated or reviewed by editors. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of the earnings call insights cannot be guaranteed. Please see full earnings call transcripts here. The earnings call insights are intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Recommended For You

More Trending News

About OGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OGN--
Organon & Co.